Finally, MGMT promoter methylation status did not show a differential pattern based on tumor grade, 62.5% (15/24) of low-grade astrocytomas and 46.8% (36/77) of high-grade astrocytomas showed MGMT hypermethylation. This evidence concerns the gene MGMT and astrocytoma (excluding glioblastoma).